Target intelligence / Profile preview

Bacterial lipooligosaccharide (LOS) antigens from Moraxella catarrhalis and nontypeable Haemophilus influenzae (LOS)

Target
LOS
Molecular classification
Glycolipid, Bacterial surface antigen, Endotoxin, Toll-like receptor 4 (TLR4) agonist
01

Overview

Bacterial lipooligosaccharides (LOS) are essential glycolipid components of the outer membrane of Gram-negative respiratory pathogens, specifically Moraxella catarrhalis and nontypeable Haemophilus influenzae (NTHi). Unlike the lipopolysaccharides (LPS) found in many enteric bacteria, LOS molecules lack the repeating O-antigen subunits, consisting instead of a conserved Lipid A anchor, a 2-keto-3-deoxy-octulosonic acid (Kdo) core, and a variable, branched oligosaccharide (Apicella, 2012; Murphy, 2015). These molecules serve as critical virulence factors that facilitate bacterial adherence to human respiratory epithelial cells, promote the formation of biofilms, and enable the bacteria to evade the host complement system through the recruitment of regulatory proteins like C4b-binding protein (Schultz et al., 2020). LOS also acts as a potent trigger for the innate immune system by activating the Toll-like receptor 4 (TLR4) complex, which drives the localized inflammatory response characteristic of otitis media and chronic obstructive pulmonary disease (COPD) exacerbations (Tan et al., 2005). Because of their prominent surface exposure and essential role in pathogenesis, LOS structures are primary targets for the development of conjugate vaccines and therapeutic monoclonal antibodies designed to elicit protective bactericidal immunity and prevent colonization (Yu et al., 2018). However, therapeutic development must address the inherent endotoxicity of the Lipid A component and the potential for molecular mimicry, where bacterial oligosaccharides resemble human glycosphingolipids to avoid immune detection.

Other names
LipooligosaccharideBacterial LOSEndotoxinLipid A-oligosaccharide complexM. catarrhalis LOSNTHi LOS
02

Mechanism of action

Induction of opsonophagocytic and bactericidal antibodies; neutralization of Lipid A-mediated TLR4 signaling; inhibition of bacterial colonization and adherence to host respiratory epithelia.

03

Biological functions

Immune responseBacterial adhesionImmune evasionSerum resistanceBiofilm formationMolecular mimicry
04

Disease associations

InfectionInflammationOtitis mediaChronic obstructive pulmonary disease (COPD) exacerbationSinusitisPneumoniaBronchitis
05

Safety considerations

Endotoxicity associated with the Lipid A moietyPotential for molecular mimicry leading to autoimmune cross-reactivity with human gangliosidesHigh antigenic variability among strains, particularly in NTHiRisk of systemic inflammatory response syndrome (SIRS) if used in non-detoxified forms
06

Interacting drugs

Polymyxin B

3 more in the full profile.

07

Biomarkers

Anti-LOS IgG antibody titersSerum bactericidal activity (SBA)Opsonophagocytic activity (OPA)Pro-inflammatory cytokine levels (e.g., IL-8, TNF-alpha)

Beyond the preview

Go deeper on Bacterial lipooligosaccharide (LOS) antigens from Moraxella catarrhalis and nontypeable Haemophilus influenzae (LOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial lipooligosaccharide (LOS) antigens from Moraxella catarrhalis and nontypeable Haemophilus influenzae (LOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call